$HQY
HEALTHEQUITY, INC.

2019 Q2 Form 10-Q Financial Statement

#000142833619000010 Filed on June 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $87.05M $69.90M
YoY Change 24.53% 26.13%
Cost Of Revenue $29.30M $25.55M
YoY Change 14.68% 17.84%
Gross Profit $57.75M $44.36M
YoY Change 30.2% 31.46%
Gross Profit Margin 66.34% 63.45%
Selling, General & Admin $17.68M $14.37M
YoY Change 23.05% 36.97%
% of Gross Profit 30.61% 32.39%
Research & Development $10.91M $7.979M
YoY Change 36.67% 27.83%
% of Gross Profit 18.88% 17.99%
Depreciation & Amortization $4.773M $4.520M
YoY Change 5.6% 29.81%
% of Gross Profit 8.26% 10.19%
Operating Expenses $30.08M $23.82M
YoY Change 26.28% 33.69%
Operating Profit $27.68M $20.54M
YoY Change 34.75% 28.96%
Interest Expense $63.00K $200.0K
YoY Change -68.5%
% of Operating Profit 0.23% 0.97%
Other Income/Expense, Net $23.60M -$1.000K
YoY Change -2360100.0% -98.89%
Pretax Income $51.28M $20.54M
YoY Change 149.66% 29.69%
Income Tax $9.456M -$2.038M
% Of Pretax Income 18.44% -9.92%
Net Earnings $41.82M $22.58M
YoY Change 85.24% 60.93%
Net Earnings / Revenue 48.04% 32.3%
Basic Earnings Per Share $0.67 $0.37
Diluted Earnings Per Share $0.65 $0.36
COMMON SHARES
Basic Shares Outstanding 62.33M shares 61.17M shares
Diluted Shares Outstanding 63.90M shares 62.69M shares

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $329.3M $269.8M
YoY Change 22.05% 37.93%
Cash & Equivalents $329.3M $228.9M
Short-Term Investments $40.90M
Other Short-Term Assets $8.244M $10.73M
YoY Change -23.17% 161.71%
Inventory $177.0K
Prepaid Expenses
Receivables $27.02M $23.02M
Other Receivables $0.00 $0.00
Total Short-Term Assets $364.6M $303.8M
YoY Change 20.02% 38.61%
LONG-TERM ASSETS
Property, Plant & Equipment $8.481M $8.626M
YoY Change -1.68% 41.81%
Goodwill $4.651M $4.651M
YoY Change 0.0% 0.0%
Intangibles $81.44M $82.15M
YoY Change -0.87% 27.0%
Long-Term Investments $209.0K $100.0K
YoY Change 109.0% -51.46%
Other Assets $21.51M $18.23M
YoY Change 18.02% 884.66%
Total Long-Term Assets $232.1M $114.3M
YoY Change 103.09% 36.51%
TOTAL ASSETS
Total Short-Term Assets $364.6M $303.8M
Total Long-Term Assets $232.1M $114.3M
Total Assets $596.6M $418.0M
YoY Change 42.73% 38.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.964M $3.112M
YoY Change -36.89% 101.42%
Accrued Expenses $9.127M $6.402M
YoY Change 42.56% 44.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.38M $17.15M
YoY Change 36.28% 66.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $387.0K $2.500M
YoY Change -84.52% 47.06%
Total Long-Term Liabilities $387.0K $3.903M
YoY Change -90.08% 129.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.38M $17.15M
Total Long-Term Liabilities $387.0K $3.903M
Total Liabilities $67.34M $21.06M
YoY Change 219.8% 75.4%
SHAREHOLDERS EQUITY
Retained Earnings $213.7M $120.5M
YoY Change 77.28% 131.45%
Common Stock $6.000K $6.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $529.3M $397.0M
YoY Change
Total Liabilities & Shareholders Equity $596.6M $418.0M
YoY Change 42.73% 38.03%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $41.82M $22.58M
YoY Change 85.24% 60.93%
Depreciation, Depletion And Amortization $4.773M $4.520M
YoY Change 5.6% 29.81%
Cash From Operating Activities $25.34M $22.70M
YoY Change 11.59% 45.76%
INVESTING ACTIVITIES
Capital Expenditures $1.126M $1.121M
YoY Change 0.45% -21.99%
Acquisitions
YoY Change
Other Investing Activities -$53.80M -$200.0K
YoY Change 26800.0% 100.0%
Cash From Investing Activities -$61.73M -$3.398M
YoY Change 1716.66% -20.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities $4.229M $10.17M
YoY Change -58.4% 165.53%
NET CHANGE
Cash From Operating Activities $25.34M $22.70M
Cash From Investing Activities -$61.73M -$3.398M
Cash From Financing Activities $4.229M $10.17M
Net Change In Cash -$32.17M $29.47M
YoY Change -209.13% 94.79%
FREE CASH FLOW
Cash From Operating Activities $25.34M $22.70M
Capital Expenditures $1.126M $1.121M
Free Cash Flow $24.21M $21.58M
YoY Change 12.17% 52.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 dei Amendment Flag
AmendmentFlag
false
CY2019Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2019Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q2 dei Document Period End Date
DocumentPeriodEndDate
2019-04-30
CY2019Q2 dei Document Type
DocumentType
10-Q
CY2019Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001428336
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62724780 shares
CY2019Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q2 dei Entity Registrant Name
EntityRegistrantName
HEALTHEQUITY INC
CY2019Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2018Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
1470000 USD
CY2019Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
1491000 USD
CY2019Q2 hqy Cost Method Investment Ownership Percentage
CostMethodInvestmentOwnershipPercentage
0.01
CY2019Q2 hqy Equity Securities Investment Ownership Percentage
EquitySecuritiesInvestmentOwnershipPercentage
0.04
CY2018Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
797000 USD
CY2019Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
141000 USD
CY2019Q2 hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-627000 USD
CY2019Q2 hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-635000 USD
CY2019Q2 hqy Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
17100000 USD
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
0.10
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited
24.36
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Granted
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitGranted
63.64
CY2019Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
0.10
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
0.10
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
44.53
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited
44.53
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Granted
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitGranted
73.61
CY2019Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2019Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2019Q2 hqy Sharebased Compensation Arrangementby Sharebased Payment Award Additional Shares Availablefor Grants Percentageof Capital Stock Outstanding Percentage
SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage
0.03
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3520000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1964000 USD
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25668000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27022000 USD
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8552000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9127000 USD
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9078000 USD
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9939000 USD
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
305223000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
315621000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4239000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6028000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
125000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000 USD
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3700000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000 USD
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2019Q1 us-gaap Assets
Assets
510016000 USD
CY2019Q2 us-gaap Assets
Assets
596639000 USD
CY2019Q1 us-gaap Assets Current
AssetsCurrent
394677000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
364576000 USD
CY2018Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1000 USD
CY2019Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1184000 USD
CY2018Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
491000 USD
CY2019Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21000 USD
CY2018Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
2100000 USD
CY2019Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
3700000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
361475000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
329310000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
199472000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228945000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
361475000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
329310000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29473000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32165000 USD
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62446000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62718000 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62446000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62718000 shares
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22577000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41822000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25548000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29299000 USD
CY2019Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1677000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
551000 USD
CY2018Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1989000 USD
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7542000 USD
CY2019Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
916000 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7332000 USD
CY2018Q2 us-gaap Depreciation
Depreciation
800000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
900000 USD
CY2018Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4520000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4773000 USD
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.099
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
CY2018Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.318
CY2019Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.045
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16981000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8501000 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
12400000 USD
CY2019Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.22
CY2019Q1 us-gaap Equity Method Investments
EquityMethodInvestments
209000 USD
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
200000 USD
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
209000 USD
CY2019Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
0 USD
CY2019Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
77400000 USD
CY2019Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
77356000 USD
CY2018Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 USD
CY2019Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
23511000 USD
CY2019Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
23500000 USD
CY2019Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
500000 USD
CY2019Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
500000 USD
CY2019Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
500000 USD
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53161000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
57045000 USD
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
132827000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
138482000 USD
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79666000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
81437000 USD
CY2018Q2 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-140000 USD
CY2019Q2 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
23484000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7507000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8709000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
4651000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
4651000 USD
CY2018Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2019Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
44356000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
57753000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20539000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
51278000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2038000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9500000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9456000 USD
CY2018Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
39000 USD
CY2019Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-51000 USD
CY2018Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
87000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1577000 USD
CY2018Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1420000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1354000 USD
CY2018Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
881000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1769000 USD
CY2018Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4909000 USD
CY2019Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8480000 USD
CY2018Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
71000 USD
CY2019Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-17000 USD
CY2018Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5471000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1694000 USD
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1523000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1575000 shares
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
79666000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
81437000 USD
CY2018Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
191000 USD
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1280000 USD
CY2018Q2 us-gaap Interest Paid Net
InterestPaidNet
50000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
50000 USD
CY2019Q2 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P11Y
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
51626000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
31930000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4288000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4233000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4205000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4105000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2865000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11597000 USD
CY2019Q1 us-gaap Liabilities
Liabilities
32937000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
67340000 USD
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
510016000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596639000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
29053000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23378000 USD
CY2019Q1 us-gaap Long Term Investments
LongTermInvestments
709000 USD
CY2019Q2 us-gaap Long Term Investments
LongTermInvestments
78065000 USD
CY2018Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10167000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4229000 USD
CY2018Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3398000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61730000 USD
CY2018Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22704000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25336000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
22577000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
41822000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
23816000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
30075000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
20540000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27678000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1074000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
40029000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3786000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36243000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
977000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37367000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0437
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y5M26D
CY2019Q1 us-gaap Other Assets Current
OtherAssetsCurrent
7534000 USD
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8244000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20413000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21511000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2968000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
387000 USD
CY2018Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
191000 USD
CY2019Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23600000 USD
CY2018Q2 us-gaap Payments For Software
PaymentsForSoftware
2097000 USD
CY2019Q2 us-gaap Payments For Software
PaymentsForSoftware
5497000 USD
CY2018Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2019Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1262000 USD
CY2018Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
180000 USD
CY2019Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
53845000 USD
CY2018Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1121000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1126000 USD
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10167000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4229000 USD
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17301000 USD
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18420000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8223000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8481000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7979000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10905000 USD
CY2018Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
3200000 USD
CY2019Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
3900000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
171850000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
213672000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69904000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87052000 USD
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
199000 USD
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6860000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8970000 USD
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4239000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6028000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3784
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3653
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.3598
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0268
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0243
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0252
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0221
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2600000.0 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.82
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
30.92
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
18000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
108000 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
85971000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
90701000 USD
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2444000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2356000 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.37
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.66
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
90701000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1503000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2356000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
29.66
CY2019Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.49
CY2019Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
73.27
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
69042000 USD
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M27D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M26D
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M13D
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y7M13D
CY2019Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
178000 shares
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
346274000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
396974000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
477079000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
529299000 USD
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1700000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1900000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1700000 USD
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62693000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63901000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61170000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62326000 shares
CY2019Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certain reclassifications have been made to&#160;prior year amounts&#160;to conform to the current year presentation.</font></div></div>

Files In Submission

Name View Source Status
0001428336-19-000010-index-headers.html Edgar Link pending
0001428336-19-000010-index.html Edgar Link pending
0001428336-19-000010.txt Edgar Link pending
0001428336-19-000010-xbrl.zip Edgar Link pending
a101amendmentno1tocreditag.htm Edgar Link pending
exhibit311-ceo302x20190430.htm Edgar Link pending
exhibit312-cfo302x20190430.htm Edgar Link pending
exhibit321-ceo906x20190430.htm Edgar Link pending
exhibit322-cfo906x20190430.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hqy-20190430.xml Edgar Link completed
hqy-20190430.xsd Edgar Link pending
hqy-20190430_cal.xml Edgar Link unprocessable
hqy-20190430_def.xml Edgar Link unprocessable
hqy-20190430_lab.xml Edgar Link unprocessable
hqy-20190430_pre.xml Edgar Link unprocessable
hqy-2019x4x3010q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending